QKA
- Product code
- QKA
- Device name
- Temporarily-Placed Urethral Opening System For Symptoms Of Benign Prostatic Hyperplasia
- Device class
- Class 2
- 21 CFR
- 21 CFR 876.5510
- Medical specialty
- Gastroenterology, Urology
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 2
- Summaries archived here
- 2 (direct download)
- 510(k) clearances (all years, FDA)
- 4 (all years; only the last 3 years are listed here)
FDA classification definition
A system intended for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men age 50 and above.
510(k) clearances, last 3 years (2)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K261342 | 2026-06-22 | Prodeon Medical, Inc. | Urocross Expander System (UES-2018-C1) | |
| K253525 | 2026-03-12 | Prodeon Medical, Inc. | Urocross Expander System (Model Numbers ES2018 and E… |
Official FDA classification page: QKA
Classification and pathway per current FDA publications. Data from openFDA (CC0).